ActRIIA Enzyme Activity Inhibitor Screening Kit Isotype control The intensity of the color

The intensity of the color is positively correlated with the amount of S100 Calcium Binding Protein A5 (S100A5) in the sample

part of the MMP gene cluster on chromosome 11

which presents advantages for drug development targeting this receptor

apoptotic cells can be observed by flow cytometry by measuring changes in light scattering

ActRIIA Enzyme Activity Inhibitor Screening Kit Isotype control The intensity of the colorProduct Specification Species Human Background STX 001, the leading program of Supercede, is a novel oral small molecule Activin Receptor Type II (ACTRII) kinase inhibitor currently in preclinical development for the treatment of obesity. In Phase II clinical studies, inhibition of the ACTRII signaling pathway has been shown to significantly reduce fat while stimulating an increase in lean body mass (muscle). For patients with obesity, achieving